Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.

Autor: Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Seo YD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Spencer CN; Parker Institute for Cancer Immunotherapy, San Francisco, California., Wortman JR; Seres Therapeutics, Cambridge, Massachusetts., Burton EM; Strategic Translational Research Initiative Development, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alayli FA; Parker Institute for Cancer Immunotherapy, San Francisco, California., Loo CP; Parker Institute for Cancer Immunotherapy, San Francisco, California., Gautam S; Parker Institute for Cancer Immunotherapy, San Francisco, California., Damania A; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., Densmore J; Parker Institute for Cancer Immunotherapy, San Francisco, California., Fairchild J; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Portage Biotech, Westport, Connecticut., Cabanski CR; Parker Institute for Cancer Immunotherapy, San Francisco, California., Wong MC; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Weiner B; Seres Therapeutics, Cambridge, Massachusetts., Hicks N; Seres Therapeutics, Cambridge, Massachusetts., Aunins J; Seres Therapeutics, Cambridge, Massachusetts., McChalicher C; Seres Therapeutics, Cambridge, Massachusetts., Walsh E; Seres Therapeutics, Cambridge, Massachusetts., Tetzlaff MT; Department of Pathology, University of California San Francisco, San Francisco, California., Hamid O; Cutaneous Oncology, The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Boland GM; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Sullivan RJ; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts., Grossmann KF; Providence Cancer Institute Franz Clinic, Portland, Oregon., Ajami NJ; Platform for Innovative Microbiome and Translational Research, Moon Shots Program, The University of Texas MD Anderson Cancer Center, Houston, Texas., LaVallee T; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Coherus BioSciences, Redwood City, California., Henn MR; Seres Therapeutics, Cambridge, Massachusetts., Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publikováno v: Cancer discovery [Cancer Discov] 2024 Jul 01; Vol. 14 (7), pp. 1161-1175.

Inhibitors of NLRP3 Inflammasome Formation: A Cardioprotective Role for the Gasotransmitters Carbon Monoxide, Nitric Oxide, and Hydrogen Sulphide in Acute Myocardial Infarction.

Autor: Payne, Fergus M.¹ (AUTHOR) fergus.payne@otago.ac.nz, Dabb, Alisha R.¹ (AUTHOR), Harrison, Joanne C.¹ (AUTHOR), Sammut, Ivan A.¹ (AUTHOR) ivan.sammut@otago.ac.nz

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9247. 26p.

Development, preparation, and testing of VAQTA^®, a highly purified hepatitis A vaccine.

Autor: Hagen, A., Aunins, J., DePhillips, P., Oswald, C. B., Hennessey Jr., J. P., Lewis, J., Armstrong, M., Oliver, C., Orella, C., Buckland, B., Sitrin, R.

Publikováno v: Bioprocess & Biosystems Engineering; Nov2000, Vol. 23 Issue 5, p439-449, 11p

Cultivation of attenuated hepatitis A virus antigen in a titanium static mixer reactor.

Autor: Junker, B. H., Seamans, T. C., Ramasubramanyan, K., Aunins, J., Paul, E., Buckland, B. C.

Publikováno v: Biotechnology & Bioengineering; Dec1994, Vol. 44 Issue 11, p1315-1324, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.